The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis
- PMID: 32740758
- PMCID: PMC8025781
- DOI: 10.1007/s11926-020-00933-4
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis
Abstract
Purpose of the review: A growing number of studies have suggested that disease outcomes and response to therapy may be different in patients with rheumatoid arthritis (RA) who are obese. The goal of this review is to examine the most recent literature, with a focus on the impact of obesity on the assessment of disease activity and treatment outcomes in RA.
Recent findings: Obesity is common in patients with RA and can have a substantial impact on patient symptoms and outcomes. Obesity is associated with higher rates of chronic pain and opiate use, elevated inflammatory markers, and less reliable physical exam findings, making assessment of disease activity and treatment response more challenging. Despite seemingly worse clinical disease activity, evidence has accumulated demonstrating that obese patients with RA have less inflammation by imaging and lower rates of radiographic progression over time. Whether obesity influences the effectiveness of specific therapies remains controversial. Obesity is very common and is associated with more severe symptoms and higher rates of disability among RA patients. While clinical disease activity is frequently observed to be higher in obese patients with RA, it remains unclear whether poorer treatment response rates in this setting are related to reduced efficacy of therapies or are an artifact of biases in the accurate assessment of the disease.
Keywords: Adiposity; Body mass index; Obesity; Rheumatoid arthritis.
Conflict of interest statement
Figures
References
-
- George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res. 2017;69(12):1789–98. 10.1002/acr.23229 - DOI - PMC - PubMed
-
This article demonstrates how excess adiposity is associated with elevation in systemic cytokines, C-Reactive Protein (CRP), and Erythrocyte Sedimentation Rate (ESR) and impacts disease activity assessment.
-
- Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–5. - PubMed
-
- Maglio C, Peltonen M, Rudin A, Carlsson LMS. Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the Swedish Obese Subjects Study. Obesity (Silver Spring). 2017;25(12):2068–73. 10.1002/oby.21955 - DOI - PMC - PubMed
-
This study demonstrates a strong relationship between metabolic obesity, psoriasis, and psoriatic arthritis, and negative effect of surgical weight reduction on incidence of psoriasis in a long term cohort study.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
